Zoetis | ZTS - Debt


Zoetis reported $9.24B in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
AbbVie USD 67.5B 67.5B Dec/2025
Align Technology USD 114.45M 6.82M Dec/2025
Bayer EUR 36.45B 2.93B Dec/2025
Bristol-Myers Squibb USD 47.14B 3.9B Dec/2025
Charles River Laboratories USD 2.57B 58.23M Dec/2025
Coherus Biosciences USD 294.92M 1.25M Mar/2025
Dentsply International USD 2.33B 137M Mar/2026
Eli Lilly USD 42.5B 3.6M Dec/2025
Henry Schein USD 3.75B 313M Mar/2026
Idexx Laboratories USD 1.11B 129.39M Mar/2026
Illumina USD 2.55B 23M Dec/2025
IQVIA Holdings USD 15.83B 109M Mar/2026
J&J USD 47.93B 2.14B Dec/2025
Laboratory Of America USD 6.53B 3.9M Dec/2025
Merck USD 49.34B 7.97B Dec/2025
Neogen USD 792.93M 396K Sep/2025
Pacira USD 367.66M 4.53M Mar/2026
Perrigo USD 3.64B 4.5M Dec/2025
Pfizer USD 63.73B 231M Mar/2026
Phibro Animal Health USD 474.17M 730K Sep/2024
Quest Diagnostics USD 6.41B 179M Mar/2026
Sanofi EUR 20.33B 1.43B Dec/2025
Sanofi EUR 21.76B 530M Sep/2025
Zoetis USD 9.24B 1.96B Dec/2025